Stockscreener 앱 받기
3.82
3.29%
-0.13
전일 마감가:
$3.95
열려 있는:
$3.82
하루 거래량:
13,459
Relative Volume:
1.62
시가총액:
$31.65M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-25.97%
1개월 성능:
-22.83%
6개월 성능:
-27.24%
1년 성능:
+0.00%
1일 변동 폭
$3.79
$3.96
1주일 범위
$3.79
$4.91
52주 변동 폭
$3.79
$16.59
Neuehealth Inc Stock (NEUE) Company Profile
명칭
Neuehealth Inc
전화
612-238-1321
주소
9250 NW 36TH STREET, DORAL
NEUE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NEUE
Neuehealth Inc
|
3.82 | 31.65M | 0 | 0 | 0 | 0.00 |
|
UNH
Unitedhealth Group Inc
|
500.13 | 460.26B | 389.07B | 14.32B | 13.10B | 15.35 |
|
ELV
Elevance Health Inc
|
365.96 | 84.87B | 174.02B | 6.42B | 871.00M | 27.43 |
|
CI
Cigna Group
|
276.92 | 77.03B | 229.75B | 3.04B | 5.18B | 10.60 |
|
CVS
Cvs Health Corp
|
44.36 | 55.82B | 368.91B | 5.02B | 1.69B | 3.94 |
|
CNC
Centene Corp
|
59.58 | 30.08B | 161.73B | 3.07B | 245.00M | 5.76 |
Neuehealth Inc Stock (NEUE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-10-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-03-29 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-03-04 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-03-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2022-01-10 | 재개 | Citigroup | Neutral |
| 2021-12-16 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2021-12-14 | 개시 | Goldman | Neutral |
| 2021-12-10 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-11-12 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-02 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2021-11-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-09-10 | 개시 | Cowen | Outperform |
| 2021-08-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-08-04 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-07-19 | 개시 | Goldman | Buy |
| 2021-07-19 | 개시 | JP Morgan | Neutral |
| 2021-07-19 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 개시 | Piper Sandler | Overweight |
| 2021-07-19 | 개시 | RBC Capital Mkts | Outperform |
| 2021-07-19 | 개시 | Wolfe Research | Peer Perform |
모두보기
Neuehealth Inc 주식(NEUE)의 최신 뉴스
neuehealth CEO George Mikan sells $70,236 in stock By Investing.com - Investing.com Canada
neuehealth CEO George Mikan sells $70,236 in stock - Investing.com
NeueHealth stock target cut, Sector Perform rating on Q3 results By Investing.com - Investing.com Canada
NeueHealth stock target cut, Sector Perform rating on Q3 results - Investing.com
MN-Based Health Company Will Move Its HQ To FL - MSN
NeueHealth Third Quarter 2024 Earnings: US$6.78 loss per share (vs US$72.52 loss in 3Q 2023) - Yahoo Finance UK
NeueHealth Inc (NEUE) Q3 2024 Earnings Call Highlights: Record Financial Performance and ... By GuruFocus - Investing.com Canada
NeueHealth Reports Strong Q3 2024 Performance - TipRanks
NeueHealth: Q3 Earnings Snapshot - CT Insider
NeueHealth shows off earnings performance, but results lag - Fierce healthcare
NeueHealth, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Neuehealth Reports Third Quarter 2024 Results - StockTitan
NeueHealth Inc (NEUE) Q3 2024 Earnings Report Preview: What to Expect - Yahoo Finance
Bright Health Beats Investor Suit Over COVID-19 Costs - Law360
NeueHealth buys full ownership of Centrum Health - MSN
Miami-Dade company buys out health firm in $102 million deal - The Business Journals
NeueHealth Inc Completes Acquisition of Centrum Health - TipRanks
NeueHealth Acquires Full Ownership of Centrum Health - Business Wire
NeueHealth to Host Third Quarter 2024 Earnings Conference Call on November 7, 2024 - StockTitan
NeueHealth CFO sells shares worth $450 By Investing.com - Investing.com South Africa
NeueHealth CFO sells shares worth $450 - Investing.com
BMW Neue Klasse Touring imagined: This is what a modern day E30 would look like according to designer 'Sugar Design' - HT Auto
HP Enterprise in focus as Citi resumes coverage; expects Juniper deal to close soon - Seeking Alpha
BMW Neue Klasse Touring Design Brings Back E30 Nostalgia In The Best Way - CarScoops
Springer Nature Aims For €4.7B Valuation In German IPO - Law360
Springer Nature Targets €4.7 Billion Valuation in Frankfurt IPO - BNN Bloomberg
DekaBank Deutsche Girozentrale Raises Stock Position in PVH Corp. (NYSE:PVH) - Defense World
Germany: Axel Springer splits media, classified businesses - DW (English)
NeueHealth (NEUE) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Vonovia aims for complete takeover of Deutsche Wohnen - Marketscreener.com
Springer Nature Plans IPO on the Frankfurt Stock Exchange - newsbreaks.infotoday.com
Wojcicki ‘Committed’ to Taking 23andMe Private as Board Quits - MSN
Telehealth & Telecare Aware - Telehealth and Telecare Aware
NEUE stock touches 52-week low at $4.86 amid market challenges - Investing.com UK
NeueHealth (NYSE:NEUE) versus Bright Health Group (NYSE:BHG) Head to Head Survey - Defense World
“I will survive” updates: NeueHealth survives Q2 with small net loss, Steward sells off Stewardship Health practices to private equity firm for $245M - Telehealth and Telecare Aware
Financial Review: Bright Health Group (NYSE:BHG) and NeueHealth (NYSE:NEUE) - Defense World
NeueHealth Second Quarter 2024 Earnings: US$6.42 loss per share (vs US$8.55 loss in 2Q 2023) - Simply Wall St
NeueHealth: Q2 Earnings Snapshot - San Antonio Express-News
NeueHealth reveals another adjusted EBITDA profit, but EPS suffers - Fierce healthcare
NeueHealth, Inc. (NEUE) Q2 2024 Earnings Call Transcript - Seeking Alpha
NeueHealth Reports Second Quarter 2024 Results - StockTitan
Bright Health Group (NYSE:BHG) and NeueHealth (NYSE:NEUE) Financial Contrast - Defense World
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Bright Health Group, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 7, 2022BHG - Marketscreener.com
NeueHealth (NEUE) to Release Earnings on Wednesday - Defense World
NeueHealth (NYSE:NEUE) Stock Quotes, Forecast and News Summary - Benzinga
NeueHealth to Host Second Quarter 2024 Earnings Conference Call on August 7, 2024 - StockTitan
Neuehealth Inc (NEUE) 재무 분석
Neuehealth Inc (NEUE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.25%
0.22%
자본화:
|
볼륨(24시간):